Consistent with the hypothesis that increased INa,L downstream of CaMKII-dependent phosphorylation of Nav1.5 increases susceptibility to obesity-induced AF, treatment with mexiletine eliminated PACs and AT/AF in WT-HFD mice (Fig. 2A–C). This evidence concerns the gene SCN5A and atrial fibrillation.